Abstract B89: The effects of raf kinase inhibition with either sorafenib or PLX-4720 on Mcl-1 expression and cytotoxicity alone and in combination with ABT-737 in melanoma cell lines
Abstract B89: The effects of raf kinase inhibition with either sorafenib or PLX-4720 on Mcl-1 expression and cytotoxicity alone and in combination with ABT-737 in melanoma cell lines
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started